| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459392 | Radiotherapy and Oncology | 2017 | 6 Pages |
Abstract
It is feasible to generate treatment plans for LA NSCLC patients on a 1.5Â T MR-Linac. Margin reduction, facilitated by an envisioned MRI-guided workflow, enables increased OAR sparing and isotoxic target dose escalation for the respective treatment approaches.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hannah E. Bainbridge, Martin J. Menten, Martin F. Fast, Simeon Nill, Uwe Oelfke, Fiona McDonald,